These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36049554)

  • 21. A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies.
    Sas MA; Comtet L; Donnet F; Mertens M; Vatansever Z; Tordo N; Pourquier P; Groschup MH
    Antiviral Res; 2018 Mar; 151():24-26. PubMed ID: 29330092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Review on Crimean-Congo Hemorrhagic Fever Infections in Tunisia.
    Rekik S; Hammami I; Timoumi O; Maghzaoua D; Khamassi Khbou M; Schulz A; Groschup MH; Gharbi M
    Vector Borne Zoonotic Dis; 2024 Jun; 24(6):325-337. PubMed ID: 38457645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and phylogenetic analysis of Crimean-Congo hemorrhagic fever virus in ticks collected from Punjab province of Pakistan.
    Shahid MF; Yaqub T; Ali M; Ul-Rahman A; Bente DA
    Acta Trop; 2021 Jun; 218():105892. PubMed ID: 33753031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
    Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
    Keshtkar-Jahromi M; Kuhn JH; Christova I; Bradfute SB; Jahrling PB; Bavari S
    Antiviral Res; 2011 May; 90(2):85-92. PubMed ID: 21362441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Nucleoprotein-Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Acute Crimean-Congo Hemorrhagic Fever Virus Infections in a Turkish Population.
    Cosgun Y; Aydemir A; Hedef H; Öz Kamiloglu A; Klemens O; Lattwein E; Klemens JM; Saschenbrecker S; Steinhagen K; Korukluoglu G
    Vector Borne Zoonotic Dis; 2023 Jan; 23(1):44-53. PubMed ID: 36576857
    [No Abstract]   [Full Text] [Related]  

  • 28. Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle.
    Surtees R; Dowall SD; Shaw A; Armstrong S; Hewson R; Carroll MW; Mankouri J; Edwards TA; Hiscox JA; Barr JN
    J Virol; 2016 Oct; 90(20):9305-16. PubMed ID: 27512070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of investigation of ticks in Volga river delta (Astrakhan region, 2017) for Crimean-Congo hemorrhagic fever virus (Nairoviridae, Orthonairovirus, CCHFV) and other tick-borne arboviruses.].
    Vakalova EV; Butenko AM; Vishnevskaya TV; Dorofeeva TE; Gitelman AK; Kulikova LN; Lvov DK; Alkhovsky SV
    Vopr Virusol; 2019; 64(5):221-228. PubMed ID: 32167687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
    Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
    Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Feldmann H
    F1000Res; 2018; 7():. PubMed ID: 30416710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current pathogenicity and potential risk evaluation of Crimean-Congo hemorrhagic fever virus to cause mysterious "Disease X"-An updated literature review.
    Jannath S; Islam MR
    Health Sci Rep; 2024 Jun; 7(6):e2209. PubMed ID: 38915357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serosurvey of Crimean-Congo Hemorrhagic Fever Virus in Cattle, Mali, West Africa.
    Maiga O; Sas MA; Rosenke K; Kamissoko B; Mertens M; Sogoba N; Traore A; Sangare M; Niang M; Schwan TG; Maiga HM; Traore SF; Feldmann H; Safronetz D; Groschup MH
    Am J Trop Med Hyg; 2017 Jun; 96(6):1341-1345. PubMed ID: 28719259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.
    Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Wang T; Yan F; Xia X
    Front Cell Infect Microbiol; 2024; 14():1341332. PubMed ID: 38746783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
    Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
    BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological survey of Crimean Congo hemorrhagic fever virus in cattle in East Darfur State, Sudan.
    Ibrahim AM; Adam IA; Osman BT; Aradaib IE
    Ticks Tick Borne Dis; 2015 Jun; 6(4):439-44. PubMed ID: 25898993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014.
    Voorhees MA; Padilla SL; Jamsransuren D; Koehler JW; Delp KL; Adiyadorj D; Baasandagwa U; Jigjav B; Olschner SP; Minogue TD; Schoepp RJ
    Emerg Infect Dis; 2018 Dec; 24(12):2202-2209. PubMed ID: 30457521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crimean-Congo hemorrhagic fever virus nucleocapsid protein harbors distinct RNA-binding sites in the stalk and head domains.
    Jeeva S; Mir S; Velasquez A; Ragan J; Leka A; Wu S; Sevarany AT; Royster AD; Almeida NA; Chan F; O'Brien L; Mir MA
    J Biol Chem; 2019 Mar; 294(13):5023-5037. PubMed ID: 30723154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.